PARLIAMENT QUESTION: RESEARCH DEVELOPMENT AND INNOVATION SCHEME
Enough facts gathered (well beyond 4, all Tier-1 PIB). Writing note now.
1. At a Glance
- RDI Scheme = ₹1 lakh crore corpus to bridge financing gap for deep-tech, research-driven, private-sector innovation via long-term, low/nil-interest debt & equity [S1][S2].
- Operates through a two-tier fund structure (Special Purpose Fund → Second-Level Fund Managers) — a novel financing architecture for Indian science funding [S3][S4].
- Fresh Parliament Q&A (29 Jul 2026) reveals scheme now shows real project sanctions (TDB, BIRAC) — moved from approval-stage to disbursement-stage. UPSC angle: tests Cabinet-to-implementation timeline and institutional linkages (ANRF, TDB, BIRAC).
2. Why in the News
- 29 Jul 2026: Lok/Rajya Sabha question answered disclosing ₹1,000 crore each sanctioned to TDB and BIRAC; TDB approved 22 projects (₹4,744 crore total cost, ₹2,192 crore RDI support); BIRAC shortlisted 8 projects (₹390.35 crore) [S1][S4].
- Follow-on/related PQs same period on RDI Fund under ANRF and low-interest long-term loans [S5][S6].
3. Background & Evolution
- 5 Feb 2024: Anusandhan National Research Foundation (ANRF) Act, 2023 (Act 25 of 2023) came into force, giving apex strategic direction to national R&D [S3].
- ANRF mandated to mobilise ₹50,000 crore (2023–28) via ANRF Fund, Innovation Fund, Science & Engineering Research Fund, and Special Purpose Funds [S3].
- 1 Sep 2025 (Cabinet approval): Cabinet approved RDI Scheme to scale up R&D in "Strategic and Sunrise Domains" [S2].
- 3 Nov 2025: RDI Scheme/Fund of ₹1 lakh crore formally launched [S3].
- Special Purpose Fund (SPF) created within ANRF as custodian of the ₹1 lakh crore corpus [S3].
- BIRAC's first national call — ₹2,000 crore RDI-linked biotech call — announced separately [S7].
4. Core Static Facts
| Parameter | Detail |
|---|---|
| Scheme name | Research, Development and Innovation (RDI) Scheme |
| Outlay | ₹1,00,000 crore over 6 years [S1] |
| Nodal/custodian body | Special Purpose Fund (SPF) within Anusandhan National Research Foundation (ANRF) [S3] |
| Parent Act | ANRF Act, 2023 (25 of 2023), in force from 5 Feb 2024 [S3] |
| Financing mode | Long-term, low/nil-interest debt & equity, refinancing [S1][S2] |
| Delivery mechanism | Second-Level Fund Managers (SLFMs) — Alternative Investment Funds (AIFs), Focused Research Organisations (FROs) [S1] |
| Eligibility threshold | Projects at Technology Readiness Level (TRL) 4 and above [S1] |
| Sectoral scope | "Strategic and Sunrise Domains" — sunrise & strategic sectors for innovation, tech adoption, competitiveness [S2] |
| Sanctions so far | ₹1,000 crore each to Technology Development Board (TDB) and Biotechnology Industry Research Assistance Council (BIRAC) = ₹2,000 crore [S1][S4] |
| TDB project pipeline | 22 projects; total cost ₹4,744 crore; RDI support ₹2,192 crore [S1][S4] |
| BIRAC project pipeline | 8 projects shortlisted; ₹390.35 crore [S1][S4] |
| Related ministry | Ministry of Science & Technology (DST) [S1] |
5. Multi-Dimensional Analysis
Economic - Targets private-sector R&D financing gap — India's private R&D spend is historically low vs GDP; RDI seeks to crowd in private capital via patient/low-cost debt [S1][S2]. - Growth & risk capital framing signals venture-style de-risking of deep-tech, unlike traditional grant-only science funding [S2].
Scientific/Technological - TRL 4+ threshold targets post-lab, pre-commercial technologies — the classic "valley of death" between research and market [S1]. - Sectoral focus: biotech (BIRAC channel), broader Technology Development Board channel — cuts across strategic (defence-adjacent, semiconductors) and sunrise (AI, biotech, clean energy) domains [S2][S7].
Administrative/Governance - Two-tier structure (ANRF-SPF → SLFMs → end recipients) adds intermediation layers (AIFs/FROs) — introduces private fund-manager discretion into public R&D financing, a governance novelty worth scrutiny [S3][S1]. - Implementation split across multiple nodal agencies (TDB, BIRAC) under one umbrella scheme — coordination and monitoring challenge [S1][S4].
Legal/Constitutional - Statutory anchor is ANRF Act, 2023 — RDI Scheme itself is executive/Cabinet-approved, not separately legislated [S2][S3].
6. Recent Developments (last 12-18 months)
- 5 Feb 2024: ANRF Act notified/in force [S3].
- 1 Sep 2025: Cabinet approves RDI Scheme [S2].
- 3 Nov 2025: RDI Fund (₹1 lakh crore) formally launched [S3].
- Late 2025: BIRAC first national call of ₹2,000 crore RDI-linked biotech funding announced [S7].
- 29 Jul 2026: Parliament disclosure — ₹1,000 crore each sanctioned to TDB/BIRAC; TDB clears 22 projects, BIRAC shortlists 8 [S1][S4].
7. Prelims Hooks
- RDI Scheme outlay: ₹1 lakh crore over 6 years [S1].
- Custodian of RDI corpus: Special Purpose Fund (SPF) within ANRF, not directly with DST [S3].
- ANRF established under ANRF Act, 2023 (Act No. 25 of 2023), in force 5 Feb 2024 [S3].
- ANRF's own 5-year (2023–28) fund mobilisation target: ₹50,000 crore — distinct from RDI's ₹1 lakh crore [S3].
- RDI eligibility floor: Technology Readiness Level (TRL) 4 and above [S1].
- Delivery channel term: Second-Level Fund Managers (SLFMs) = AIFs + Focused Research Organisations (FROs) [S1].
- Amount sanctioned each to TDB and BIRAC: ₹1,000 crore (total ₹2,000 crore) [S1][S4].
- TDB approved projects: 22, total project cost ₹4,744 crore, RDI support ₹2,192 crore [S1][S4].
- BIRAC shortlisted: 8 projects, worth ₹390.35 crore [S1][S4].
- Cabinet approved RDI Scheme on 1 September 2025 [S2].
- RDI Scheme formally launched 3 November 2025 [S3].
- Scheme covers "Strategic and Sunrise Domains" per Cabinet approval title [S2].
- Financing instruments: debt and equity, at low/nil interest, long tenor [S1][S2].
- BIRAC's first national RDI-linked biotech call size: ₹2,000 crore [S7].
8. Mains Relevance
- GS-III: Science & Technology — indigenization of technology, developments in application of science & technology; also Indian Economy — investment models, growth capital.
- GS-II (secondary): Government policies/interventions for development in S&T sectors.
- Sample stems: 1. "Discuss how the Research, Development and Innovation (RDI) Scheme seeks to bridge India's deep-tech financing gap. Examine institutional challenges in a multi-tier fund-manager model." (GS-III) 2. "Critically examine the relationship between the Anusandhan National Research Foundation and the RDI Scheme in India's research funding architecture." (GS-II/III) 3. "Private capital, public mandate — assess risks of routing sovereign R&D funds through Alternative Investment Funds and Focused Research Organisations." (GS-III, governance angle)
9. Related Topics to Study Next
- Anusandhan National Research Foundation (ANRF) — parent statutory body governing RDI Fund [S3].
- Technology Development Board (TDB) — implementing agency, pre-dates RDI, DSIR-linked.
- BIRAC (Biotechnology Industry Research Assistance Council) — Dept. of Biotechnology PSU channel for biotech deep-tech.
- Deep Tech Fund of Funds — parallel/complementary innovation financing vehicle under discussion in Parliament [from search: PRID=2226469].
- Technology Readiness Level (TRL) framework — DRDO/ISRO-origin classification now central to funding eligibility.
- Alternative Investment Funds (AIF) regulatory framework (SEBI) — governs SLFM structuring.
- National Deep Tech Startup Policy — sectoral overlap with RDI's sunrise-domain focus.
10. Common Errors / Trap Areas
- Confusing RDI Scheme (₹1 lakh crore, Cabinet scheme, 2025) with ANRF's own ₹50,000 crore (2023-28) mobilisation target — these are separate corpora [S1][S3].
- Assuming RDI Fund is directly administered by DST — actual custodian is the SPF within ANRF, disbursed via SLFMs, not a direct ministry grant [S3].
- Mixing up TDB (Technology Development Board, cross-sector) with BIRAC (biotech-specific) — both got ₹1,000 crore each but serve different domains [S1][S4].
- Assuming RDI Scheme needs separate parliamentary legislation — it is a Cabinet-approved scheme under the existing ANRF Act, 2023 framework, not a new Act [S2][S3].
- TRL floor is 4, not TRL 1 (basic research) — RDI targets post-proof-of-concept, pre-commercialisation stage only [S1].
11. Sources
- [S1] PARLIAMENT QUESTION: RESEARCH DEVELOPMENT AND INNOVATION SCHEME — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2291145 — (tier: 1)
- [S2] Cabinet Approves Research Development and Innovation (RDI) Scheme to scale up Research, Development and Innovation in Strategic and Sunrise Domains — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2141130 — (tier: 1)
- [S3] ANRF Executive Council approves major decisions regarding operationalization of RDI Fund — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2177845 — (tier: 1)
- [S4] PARLIAMENT QUESTION: RESEARCH DEVELOPMENT AND INNOVATION SCHEME (search-aggregated TDB/BIRAC figures, corroborating S1) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2238346 — (tier: 1)
- [S5] PARLIAMENT QUESTION: RDI FUND UNDER ANRF — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2288307 — (tier: 1)
- [S6] PARLIAMENT QUESTION: LOW-INTEREST, LONG-TERM LOANS/FINANCIAL GRANTS UNDER RDI SCHEME — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2291143 — (tier: 1)
- [S7] Dr Jitendra Singh Announces First National Call of ₹2,000 Crore BIRAC–RDI Fund — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2227506 — (tier: 1)